Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

| More on:
A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Many of Australia's top brokers have been busy adjusting their financial models again. This has led to the release of a number of broker notes this week.

Three ASX shares that brokers have named as buys this week are listed below. Here's why they are feeling bullish on them right now:

Hub24 Ltd (ASX: HUB)

According to a note out of Morgan Stanley, its analysts have retained their overweight rating and $44.00 price target on this investment platform provider's shares. This follows the release of the company's third-quarter update this week. Morgan Stanley highlights that the company's platform funds under administration (FUA) of $79.7 billion came in ahead of its estimates. In light of this and higher seasonal flows, the broker sees scope for the company to outperform in the fourth quarter. The broker was also pleased to see management reaffirm its guidance for platform FUA to reach $92 billion to 100 billion in FY 2025. The HUB24 share price is trading at $39.62 this afternoon.

Pro Medicus Limited (ASX: PME)

A note out of Goldman Sachs reveals that its analysts have initiated coverage on this health imaging company's shares with a buy rating and $134.00 price target. The broker sees Pro Medicus as the clear incumbent technology leader in a growing market with a strong financial profile and significant artificial intelligence upside. Goldman believes that the company's Visage 7 platform is core to many healthcare institutions, providing efficiency gains in a market where demand for imaging continues to grow and radiologist shortages persist. It thinks it can increase its US market share to 13% in FY 2030 from ~7% today. The Pro Medicus share price is fetching $101.94 on Wednesday.

Zip Co Ltd (ASX: ZIP)

Analysts at UBS have retained their buy rating on this buy now pay later provider's shares with an improved price target of $1.55. This follows the release of the company's third-quarter update this week which revealed a 14.6% increase in total transaction volume and a 26.6% jump in revenue. UBS was pleased with the stronger-than-expected update. It notes that it was driven by a particularly strong performance from its Zip Americas business. And while it was slightly disappointed with the performance of the Zip AU business, it believes this will stabilise in FY 2025 and then return to growth. Overall, the broker was impressed and its earnings estimates have been revised higher. The Zip share price is trading at $1.14 on Wednesday afternoon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Hub24, Pro Medicus, and Zip Co. The Motley Fool Australia has recommended Hub24 and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Three cute kids with mixed expressions poke their heads out from the back of a kombi.
Broker Notes

Top brokers just downgraded these ASX 200 shares

Is the tide turning for these names?

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

These ASX shares could rise 20% to 45%

Analysts are tipping these stocks to smash the market in 2025.

Read more »

Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Hands reaching high for a trophy with a sunset in the background.
Broker Notes

IAG shares hit multi-year high amid broker prediction of double-digit profit growth

Morgan Stanley has issued a new note on the ASX insurance sector.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

This ASX All Ords stock could rise 25% and pay a 5% yield

Bell Potter has good things to say about this stock. Let's see why it is bullish.

Read more »

Happy man working on his laptop.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Broker Notes

These ASX 200 shares could rise 20% to 65%

Analysts are tipping these shares to deliver big returns in 2025.

Read more »